Moderna, Inc. (MRNA)
Every FINRA and SEC series the site collects for Moderna, Inc.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq.
39.2M
Short interest
settlement 2026-08-31
1.0
Days to cover
-25.9% vs prior
61.1%
Short share of volume
2026-09-11
1,866
Fails to deliver
settlement 2026-08-14
-$29.2M
Insider flow, 90 days
0 buys, 5 sells
As of 2026-09-11.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 31 August 2026, short interest in MRNA is 39,151,532 shares, down 10,617,350 shares over the last month. Over the last 48 readings it ranged from 27,613,114 shares (13 September 2024) to 71,505,698 shares (30 January 2026). At the reported average volume of 50.2M shares a day that is 1.0 days to cover.
Embed this chartkeeps the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/mrna" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-31 | 39,151,532 | -25.9% | 50,157,233 | 1.00 |
| 2026-08-14 | 52,809,184 | +6.1% | 5,773,145 | 9.15 |
| 2026-07-31 | 49,768,882 | -5.0% | 4,868,200 | 10.22 |
| 2026-07-15 | 52,401,842 | -1.5% | 8,626,893 | 6.07 |
| 2026-06-30 | 53,185,640 | -9.3% | 11,529,682 | 4.61 |
| 2026-06-15 | 58,664,960 | +1.5% | 5,598,691 | 10.48 |
| 2026-05-29 | 57,806,124 | -0.5% | 4,710,739 | 12.27 |
| 2026-05-15 | 58,071,415 | -0.4% | 10,322,790 | 5.63 |
| 2026-04-30 | 58,309,643 | -1.9% | 5,747,583 | 10.15 |
| 2026-04-15 | 59,437,562 | -2.0% | 5,192,193 | 11.45 |
| 2026-03-31 | 60,649,602 | -8.4% | 6,704,912 | 9.05 |
| 2026-03-13 | 66,188,177 | -5.8% | 10,748,221 | 6.16 |
| 2026-02-27 | 70,233,907 | -1.6% | 8,688,614 | 8.08 |
| 2026-02-13 | 71,341,687 | -0.2% | 10,886,356 | 6.55 |
| 2026-01-30 | 71,505,698 | +1.8% | 15,740,115 | 4.54 |
| 2026-01-15 | 70,268,867 | +2.9% | 13,291,708 | 5.29 |
| 2025-12-31 | 68,321,865 | -1.9% | 9,920,925 | 6.89 |
| 2025-12-15 | 69,679,477 | +2.4% | 10,101,670 | 6.90 |
| 2025-11-28 | 68,075,313 | +5.8% | 9,366,839 | 7.27 |
| 2025-11-14 | 64,356,094 | +1.1% | 11,379,459 | 5.66 |
| 2025-10-31 | 63,656,197 | -2.1% | 12,160,619 | 5.23 |
| 2025-10-15 | 65,036,951 | +1.1% | 9,397,529 | 6.92 |
| 2025-09-30 | 64,337,988 | +1.6% | 11,546,655 | 5.57 |
| 2025-09-15 | 63,310,000 | +5.8% | 13,053,475 | 4.85 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 11 September 2026, the short share of MRNA volume is 61.1%, up 8.1 points over the last five sessions. Over the last 52 readings it ranged from 36.5% (29 July 2026) to 76.5% (6 July 2026). The latest reading is 2.9 points above the 30-session average of 58.2%, on 7.7M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-11 | 4.7M | 7.7M | 61.1% | 13,420 |
| 2026-09-10 | 2.0M | 3.7M | 53.3% | 1,061 |
| 2026-09-09 | 2.2M | 4.0M | 55.0% | 2,488 |
| 2026-09-08 | 2.5M | 4.7M | 53.6% | 25,948 |
| 2026-09-04 | 4.1M | 7.6M | 54.1% | 13,909 |
| 2026-09-03 | 3.4M | 6.4M | 53.1% | 26,837 |
| 2026-09-02 | 5.4M | 8.5M | 62.7% | 16,878 |
| 2026-09-01 | 8.7M | 14.6M | 59.6% | 24,659 |
| 2026-08-31 | 6.1M | 9.9M | 61.5% | 32,312 |
| 2026-08-28 | 10.6M | 14.3M | 74.5% | 92,155 |
| 2026-08-27 | 7.1M | 11.1M | 64.0% | 14,943 |
| 2026-08-26 | 7.2M | 11.8M | 60.6% | 14,814 |
| 2026-08-25 | 17.2M | 26.9M | 63.8% | 2,189,720 |
| 2026-08-24 | 10.8M | 17.4M | 62.3% | 1,116,582 |
| 2026-08-21 | 24.9M | 49.9M | 49.8% | 4,013,532 |
| 2026-08-20 | 28.4M | 49.3M | 57.6% | 3,310,905 |
| 2026-08-19 | 42.0M | 88.2M | 47.6% | 146,099 |
| 2026-08-18 | 929K | 1.5M | 60.1% | 275 |
| 2026-08-17 | 952K | 1.6M | 59.6% | 313 |
| 2026-08-14 | 1.1M | 2.2M | 50.1% | 0 |
| 2026-08-13 | 1.5M | 2.8M | 53.8% | 2,984 |
| 2026-08-12 | 1.6M | 2.4M | 65.9% | 4,733 |
| 2026-08-11 | 1.6M | 2.7M | 59.9% | 6,065 |
| 2026-08-10 | 1.7M | 2.8M | 62.0% | 5,204 |
| 2026-08-07 | 1.9M | 2.9M | 66.2% | 1,891 |
| 2026-08-06 | 1.2M | 2.2M | 52.4% | 2,557 |
| 2026-08-05 | 1.0M | 2.0M | 51.0% | 1,199 |
| 2026-08-04 | 819K | 1.4M | 56.5% | 2,981 |
| 2026-08-03 | 1.1M | 2.0M | 52.8% | 4,252 |
| 2026-07-31 | 2.1M | 3.4M | 61.4% | 6,096 |
Fails to deliver
SEC, by settlement date. JSONAs of 14 August 2026, the fails-to-deliver balance in MRNA is 1,866 shares, down 828 shares over the last settlement date. Over the last 52 readings it ranged from 5 shares (5 June 2026) to 429,900 shares (30 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-14 | 1,866 | $63.65 | $119K |
| 2026-08-13 | 2,694 | $63.67 | $172K |
| 2026-08-12 | 31,497 | $60.57 | $1.9M |
| 2026-08-11 | 62 | $59.81 | $4K |
| 2026-08-05 | 14 | $56.99 | $798 |
| 2026-08-04 | 5,011 | $55.14 | $276K |
| 2026-08-03 | 2,177 | $54.82 | $119K |
| 2026-07-31 | 136,000 | $57.92 | $7.9M |
| 2026-07-30 | 429,900 | $54.49 | $23.4M |
| 2026-07-29 | 224,227 | $55.81 | $12.5M |
| 2026-07-28 | 78 | $55.63 | $4K |
| 2026-07-27 | 21,404 | $54.07 | $1.2M |
| 2026-07-23 | 49 | $58.07 | $3K |
| 2026-07-21 | 57,964 | $59.49 | $3.4M |
| 2026-07-20 | 177,421 | $61.82 | $11.0M |
| 2026-07-17 | 3,198 | $63.15 | $202K |
| 2026-07-16 | 3,180 | $68.28 | $217K |
| 2026-07-15 | 708 | $67.44 | $48K |
| 2026-07-14 | 62,813 | $67.01 | $4.2M |
| 2026-07-09 | 1,014 | $73.80 | $75K |
| 2026-07-06 | 8,830 | $79.76 | $704K |
| 2026-07-02 | 2,019 | $72.50 | $146K |
| 2026-07-01 | 49,658 | $70.03 | $3.5M |
| 2026-06-30 | 60,788 | $69.70 | $4.2M |
| 2026-06-29 | 89,973 | $67.27 | $6.1M |
| 2026-06-26 | 8,386 | $59.75 | $501K |
| 2026-06-25 | 6,965 | $60.42 | $421K |
| 2026-06-24 | 1,563 | $61.00 | $95K |
| 2026-06-23 | 508 | $59.35 | $30K |
| 2026-06-22 | 90,770 | $63.96 | $5.8M |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at MRNA reported 5 open-market sells worth $29.2M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Klinger Shannon Thyme (Chief Legal Officer) on 2026-09-01.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Klinger Shannon Thyme | Chief Legal Officer | Sell | 3K | $139.95 | $486K | 74K |
| 2026-09-01 | Klinger Shannon Thyme | Chief Legal Officer | Option exercise | 3K | $30.96 | $107K | 78K |
| 2026-08-06 | Bancel Stephane | Chief Executive Officer | Option exercise | 252K | $19.15 | $4.8M | 6.4M |
| 2026-08-05 | Bancel Stephane | Chief Executive Officer | Sell | 187K | $58.79 | $11.0M | 6.2M |
| 2026-08-05 | Bancel Stephane | Chief Executive Officer | Sell | 40K | $58.12 | $2.3M | 6.4M |
| 2026-08-05 | Bancel Stephane | Chief Executive Officer | Sell | 125K | $56.96 | $7.1M | 6.4M |
| 2026-08-05 | Bancel Stephane | Chief Executive Officer | Sell | 147K | $56.21 | $8.3M | 6.5M |
| 2026-08-05 | Bancel Stephane | Chief Executive Officer | Option exercise | 499K | $19.15 | $9.6M | 6.7M |
| 2026-06-15 | Hoge Stephen | President | Sell | 53K | $51.37 | $2.7M | 1.5M |
| 2026-06-15 | Hoge Stephen | President | Option exercise | 37K | $19.15 | $713K | 1.5M |
| 2026-06-15 | Hoge Stephen | President | Option exercise | 16K | $19.15 | $309K | 1.5M |
| 2026-06-05 | Mock James M | Chief Financial Officer | Option exercise | 12K | n/a | n/a | 71K |
| 2026-06-05 | Mock James M | Chief Financial Officer | Tax withholding | 6K | $51.59 | $294K | 66K |
| 2026-06-05 | Klinger Shannon Thyme | Chief Legal Officer | Option exercise | 12K | n/a | n/a | 79K |
| 2026-06-05 | Klinger Shannon Thyme | Chief Legal Officer | Tax withholding | 6K | $51.59 | $294K | 74K |
| 2026-06-04 | Klinger Shannon Thyme | Chief Legal Officer | Sell | 3K | $50.00 | $174K | 67K |
| 2026-06-04 | Klinger Shannon Thyme | Chief Legal Officer | Option exercise | 3K | $30.96 | $107K | 71K |
| 2026-06-01 | Hoge Stephen | President | Option exercise | 9K | n/a | n/a | 1.5M |
| 2026-06-01 | Hoge Stephen | President | Tax withholding | 4K | $47.19 | $212K | 1.5M |
| 2026-06-01 | Klinger Shannon Thyme | Chief Legal Officer | Tax withholding | 1K | $47.19 | $49K | 67K |
| 2026-06-01 | Klinger Shannon Thyme | Chief Legal Officer | Option exercise | 2K | n/a | n/a | 69K |
| 2026-06-01 | Mock James M | Chief Financial Officer | Tax withholding | 1K | $47.19 | $56K | 60K |
| 2026-06-01 | Mock James M | Chief Financial Officer | Option exercise | 2K | n/a | n/a | 61K |
| 2026-05-28 | Hoge Stephen | President | Option exercise | 610 | n/a | n/a | 1.5M |
| 2026-05-28 | Hoge Stephen | President | Tax withholding | 295 | $47.61 | $14K | 1.5M |
| 2026-05-28 | Klinger Shannon Thyme | Chief Legal Officer | Option exercise | 328 | n/a | n/a | 67K |
| 2026-05-28 | Klinger Shannon Thyme | Chief Legal Officer | Tax withholding | 159 | $47.61 | $8K | 66K |
| 2026-05-28 | Mock James M | Chief Financial Officer | Option exercise | 328 | n/a | n/a | 58K |
| 2026-05-28 | Mock James M | Chief Financial Officer | Tax withholding | 159 | $47.61 | $8K | 58K |
| 2026-05-27 | Hoge Stephen | President | Tax withholding | 695 | $47.03 | $33K | 1.5M |
| 2026-05-27 | Hoge Stephen | President | Option exercise | 1K | n/a | n/a | 1.5M |
| 2026-05-27 | Klinger Shannon Thyme | Chief Legal Officer | Option exercise | 773 | n/a | n/a | 67K |
| 2026-05-27 | Klinger Shannon Thyme | Chief Legal Officer | Tax withholding | 374 | $47.03 | $18K | 66K |
| 2026-05-27 | Mock James M | Chief Financial Officer | Option exercise | 773 | n/a | n/a | 59K |
| 2026-05-27 | Mock James M | Chief Financial Officer | Tax withholding | 374 | $47.03 | $18K | 58K |
| 2026-05-21 | AFEYAN NOUBAR | n/a | Sell | 9K | $46.84 | $434K | 4K |
| 2026-05-21 | AFEYAN NOUBAR | n/a | Option exercise | 9K | $19.15 | $177K | 13K |
| 2026-05-15 | Hoge Stephen | President | Sell | 53K | $48.40 | $2.6M | 1.5M |
| 2026-05-15 | Hoge Stephen | President | Option exercise | 16K | $19.15 | $309K | 1.5M |
| 2026-05-15 | Hoge Stephen | President | Option exercise | 37K | $19.15 | $713K | 1.5M |
| 2026-05-01 | Hussain Abbas | Director | Sell | 6K | $46.63 | $265K | 12K |
| 2026-04-30 | Tallett Elizabeth E | Director | Option exercise | 4K | n/a | n/a | 5K |
| 2026-04-30 | Nader Francois | Director | Option exercise | 12K | n/a | n/a | 33K |
| 2026-04-30 | NABEL ELIZABETH G | Director | Option exercise | 16K | n/a | n/a | 19K |
| 2026-04-30 | Hussain Abbas | Director | Option exercise | 16K | n/a | n/a | 18K |
| 2026-04-30 | Rubenstein David M. | Director | Option exercise | 8K | n/a | n/a | 10K |
| 2026-04-30 | Horning Sandra | Director | Option exercise | 16K | n/a | n/a | 19K |
| 2026-04-02 | Mock James M | Chief Financial Officer | Tax withholding | 703 | $50.03 | $35K | 58K |
| 2026-04-02 | Mock James M | Chief Financial Officer | Option exercise | 1K | n/a | n/a | 58K |
| 2026-03-05 | Mock James M | Chief Financial Officer | Tax withholding | 6K | $57.80 | $330K | 57K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON4 Form 144 notices on file for MRNA worth $37.7M at the prices reported; 4 in the last 90 days worth $37.7M. Latest: Mock James M filed on 2026-09-10 to sell 34,836 shares ($4.7M) from 2026-09-10.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-10 | Mock James MOfficer | 35K | $4.7M | 0.009% | 2026-09-10 | Fidelity Brokerage Services LLC |
| 2026-09-01 | Klinger Shannon ThymeOfficer | 3K | $486K | 0.001% | 2026-09-01 | Fidelity Brokerage Services LLC |
| 2026-08-05 | Bancel StephaneOfficer, Director | 499K | $29.0M | 0.125% | 2026-08-05 | Fidelity Brokerage Services LLC |
| 2026-07-15 | Hoge StephenOfficer | 53K | $3.6M | 0.013% | 2026-07-15 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON6 holders above 5% have filed on MRNA, all on Schedule 13G (passive). The largest reported stake is FMR LLC at 13.1% of the class (51,803,891 shares), filed 2026-08-06 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-12 | 13G | Capital World Investorsinvestment adviser | 22.3M | 5.6% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 2 | FMR LLCparent holding company | 51.8M | 13.1% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 2 | Abigail P. Johnsonindividual | 51.8M | 13.1% | 2026-06-30 |
| 2026-07-24 | 13G/Ano. 7 | BAILLIE GIFFORD & COinvestment adviser | 18.2M | 4.6% | 2026-06-30 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 25.9M | 6.5% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 6 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-09 | 13G/Ano. 6 | BAILLIE GIFFORD & COinvestment adviser | 20.6M | 5.3% | 2025-12-31 |
| 2026-02-06 | 13G/Ano. 1 | FMR LLCparent holding company | 41.3M | 10.6% | 2026-01-30 |
| 2026-02-06 | 13G/Ano. 1 | Abigail P. Johnsonindividual | 41.3M | 10.6% | 2026-01-30 |
| 2026-02-05 | 13G | FMR LLCparent holding company | 28.0M | 7.2% | 2025-12-31 |
| 2026-02-05 | 13G | Abigail P. Johnsonindividual | 28.0M | 7.2% | 2025-12-31 |
| 2025-11-05 | 13G/Ano. 1 | FMR LLCparent holding company | 12.3M | 3.2% | 2025-09-30 |
| 2025-11-05 | 13G/Ano. 1 | Abigail P. Johnsonindividual | 12.3M | 3.2% | 2025-09-30 |
13F holders
Tracked managers holding MRNA at their latest 13F. JSON8 of the 30 tracked managers held MRNA at their latest 13F, $1.25B in total at quarter-end prices. Two Sigma Investments is the largest at $507.2M (0.4% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 6 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 7.2M | $507.2M | 0.37% | -2.0M |
| Citadel Advisors | 2026-06-30 | 6.2M | $436.5M | 0.05% | -833K |
| D. E. Shaw & Co. | 2026-06-30 | 2.9M | $200.7M | 0.10% | -2.5M |
| Millennium Management | 2026-06-30 | 729K | $51.0M | 0.02% | -494K |
| AQR Capital Management | 2026-06-30 | 479K | $33.6M | 0.01% | +441K |
| Point72 Asset Management | 2026-06-30 | 222K | $15.5M | 0.02% | -493K |
| Bridgewater Associates | 2026-06-30 | 12K | $807K | 0.00% | -63K |
| Fisher Asset Management | 2026-06-30 | 11K | $760K | 0.00% | +5K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 2026 (quarter ended 2026-06-30) Moderna, Inc. reported revenue of $145.0M, up 2.1% from the same quarter a year earlier, and net loss of $782.0M (-1.97 diluted EPS). In FY 2025 it generated -$1.87B of operating cash flow and spent $2.0M on buybacks. As of 2026-06-30, cash was $1.72B against $591.0M of debt.
- Cash
- $1.72B
- Debt
- $591.0M
- Equity
- $6.76B
- Total assets
- $10.96B
- Shares outstanding
- 399,235,889
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $145.0M | -$782.0M | -539.3% | -1.97 |
| Q1 2026 | 2026-03-31 | $389.0M | -$1.34B | -345.2% | -3.40 |
| Q4 2025derived | 2025-12-31 | $678.0M | -$826.0M | -121.8% | n/a |
| Q3 2025 | 2025-09-30 | $1.02B | -$200.0M | -19.7% | -0.51 |
| Q2 2025 | 2025-06-30 | $142.0M | -$825.0M | -581.0% | -2.13 |
| Q1 2025 | 2025-03-31 | $108.0M | -$971.0M | -899.1% | -2.52 |
| Q4 2024derived | 2024-12-31 | $966.0M | -$1.12B | -115.9% | n/a |
| Q3 2024 | 2024-09-30 | $1.86B | $13.0M | 0.7% | 0.03 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1.94B | -$2.82B | -$1.87B | $192.0M | $2.0M | n/a |
| FY 2024 | 2024-12-31 | $3.24B | -$3.56B | -$3.00B | $1.05B | $0 | n/a |
| FY 2023 | 2023-12-31 | $6.85B | -$4.71B | -$3.12B | $707.0M | $1.15B | n/a |
| FY 2022 | 2022-12-31 | $19.26B | $8.36B | $4.98B | $400.0M | $3.33B | n/a |
| FY 2021 | 2021-12-31 | $18.47B | $12.20B | $13.62B | $284.0M | $857.0M | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-24 from the cover page.
What this page is
Moderna, Inc. in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows Moderna, Inc. (MRNA), SEC CIK 1682852, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-09-10.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-12.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-01.JSON and CSV
- Company record
- EDGAR filing index for CIK 1682852Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 14 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- TEAMAtlassian Corp
- CVNACARVANA CO.
- CRMSalesforce, Inc.
- METAMeta Platforms, Inc.
- UTHRUNITED THERAPEUTICS Corp
- CRWVCoreWeave, Inc.
- RCGRENN Fund, Inc.
- ANETArista Networks, Inc.
- DDOGDatadog, Inc.
- NETCloudflare, Inc.
- DELLDell Technologies Inc.
- GOOGAlphabet Inc.
- CRWDCrowdStrike Holdings, Inc.
- TPLTexas Pacific Land Corp
- COINCoinbase Global, Inc.
- NOWServiceNow, Inc.
- MORNMorningstar, Inc.
- CPIXCUMBERLAND PHARMACEUTICALS INC
- DASHDoorDash, Inc.
- ZMZoom Communications, Inc.
- TDGTransDigm Group INC
- UBERUber Technologies, Inc
- PCTYPaylocity Holding Corp
- GSHDGoosehead Insurance, Inc.
Datasets
Frequently Asked Questions
How much of MRNA is sold short?
What is MRNA's daily short volume?
Does MRNA have fails to deliver?
Are MRNA insiders buying or selling?
Have MRNA insiders filed to sell?
Who owns more than 5% of MRNA?
What did MRNA report last quarter?
Which funds hold MRNA?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.